Aisling Capital Management LP Marker Therapeutics, Inc. Transaction History

Aisling Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.28 - $3.12 $791,999 - $8.83 Million	-2,828,571 Reduced 90.0%	314,286 $223,000
Q1 2021 May 14, 2021	BUY	$1.47 - $3.29 $1.68 Million - $3.76 Million	1,142,857 Added 57.14%	3,142,857 $7.04 Million
Q4 2018 Feb 08, 2019	BUY	$4.2 - $9.74 $8.4 Million - $19.5 Million	2,000,000 New	2,000,000 $11.1 Million

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $255M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Aisling Capital Management LP with notifications on news.